Stool Sample Collection & Stabilization Kit
Referentie SC0012
Formaat : 100units
Merk : Canvax Biotech
Neem contact op met een lokale distributeur :
Telefoonnummer : +1 850 650 7790
Stool Sample Collection & Stabilization Kit
For a Convenient, Versatile & Easy Collection, Transportation and Storage of Stool samples for Microbiome Analysis
Stool Sample Collection & Stabilization is a convenient, versatile and easy-to-use kit ideal for collection, transportation and storage of Stool samples using a DNA stabilization buffer. It prevents degradation of DNA and ensures nucleic acid stability. The stabilized samples can be stored for several months at Room Temperature and indefinitely at -20º C or -80º C.
Detailed information:
Advantages & Features
- Easy to self-collect.
- Proven Performance for Quantitative Gut Microbiome profile analysis.
- Cost avoidance: ship stool samples at Room Temperature.
- High quality samples obtained without need to process immediately.
- Versatile: compatible with various DNA purification kits.
- Convenient: eliminates odor during processing.
- Fast protocol: results in few minutes.
Specifications
Includes
Includes for 100 units:
– 100 Stool Collection & Stabilization tubes pre-filled with 8 mL of DNA Stabilization Buffer
– 1 Product Insert
Download documentation
Datasheet MSDSApplications
- DNA Isolation: DNA can be purified from the preserved stool sample.
Tables & Figures
Quality Control
- DNA isolated from 200 mg feces preserved with our sample collection kit quantified by spectrophotometer and analysed by electrophoreshis.
Advice
For DNA Purification/Extraction, we highly recommend the use HigherPurity™ Stool DNA Extraction Kit.
Storage, Shipping & Guarantee
- Shipped in: Ambient Temperature.
- Storage: Room Temperature (15–25 °C).
Citations
- Macandog, A. D., Catozzi, C., Capone, M., Nabinejad, A., Nanaware, P. P., Liu, S., … & Nezi, L. (2024). Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients. Cell Host & Microbe, 32(11), 2004-2018.
- T. Sønderby Bruun and A. Varmløse Strathe (2024). Effect of feeding docosahexaenoic acid to sows on milk composition and microbiota of sows and piglets. Poster communication at BOLFA & ICFAE Conference.
- Zhai, X., Castro-Mejía, J. L., Gobbi, A., Aslampaloglou, A., Kot, W., Nielsen, D. S., & Deng, L. (2023). The impact of storage buffer and storage conditions on fecal samples for bacteriophage infectivity and metavirome analysis.
- Sisti, D., Pazienza, V., Piccini, F., Citterio, B., Baffone, W., Donati Zeppa, S., … & Gobbi, P. (2022). A proposal for the reference intervals of the Italian microbiota “scaffold” in healthy adults. Scientific reports, 12(1), 1-13.
- Fortunato Ciardiello (2021). CAPRI 2 GOIM study: investigate the efficacy and safety of a bio- marker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF wt tumors at start of first line.
- Hansen, E. B., Nielsen, D. S., & LaPointe, G. (2021). MIFFI THEMATIC ISSUE 2021.
- Manchia, Mirko, et al. “Involvement of Gut Microbiota in Schizophrenia and Treatment Resistance to Antipsychotics.” Biomedicines 9.8 (2021): 875.
- Svensson, R. (2021). Development of northern pike (Esox lucius) populations in the Baltic Sea, and potential effects of grey seal (Halichoerus grypus) predation.
- Picchianti Diamanti, A., Panebianco, C., Salerno, G., Di Rosa, R., Salemi, S., Sorgi, M. L., … & Sesti, G. (2020). Impact of Mediterranean Diet on Disease Activity and Gut Microbiota Composition of Rheumatoid Arthritis Patients. Microorganisms, 8(12), 1989.
- Trivieri, N., Pracella, R., Cariglia, M. G., Panebianco, C., Parrella, P., Visioli, A., … & Latiano, T. P. (2020). BRAF V600E mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies. Journal of Experimental & Clinical Cancer Research, 39(1), 1-16.
- Picchianti-Diamanti, A., Panebianco, C., Salemi, S., Sorgi, M., Di Rosa, R., Tropea, A., … & Laganà, B. (2018). Analysis of Gut Microbiota in Rheumatoid Arthritis Patients: Disease-Related Dysbiosis and Modifications Induced by Etanercept. International Journal of Molecular Sciences, 19(10), 2938.
Safety Statements
This product is developed, designed and sold exclusively for Research purposes and in vitro use only (RUO). The product was not tested for use in diagnostics or for drug development, nor is it suitable for administration to humans or animals. For more info, please check its Material Safety Data Sheet available in this website.